Efficacy and safety of SENS-501, a dual-AAV otoferlin gene therapy, for DFNB9 congenital deafness

Molecular Therapy Advances · Elsevier

Аннотация

Publication date: 10 September 2026 Source: Molecular Therapy Advances, Volume 34, Issue 3 Author(s): Rafik Boudra, Guillaume Olivier, Christophe Tran Van Ba, Lise Barrot, Pierre Rambeau, Charlène Vaux, Sandra Pierredon, Charlène Joséphine, Anaïs Pages, Audrey Broussy, Anne-Gabrielle Harrus, Selma Dadak, Pauline Liaudet, Géraldine H. Petit, Ophélie Poujade, Jérôme Nevoux, Ghizlene Lahlou, Natalie Loundon, Christine Le Bec, Emilie Bousquet

Читать у издателя →

Похожие статьи